INS and hepatocellular carcinoma: Our data indicate that deletion of ChREBP delays insulin-induced hepatocarcinogenesis, suggesting a combined oncogenic and lipogenic function of ChREBP along with AKT/mTOR-mediated proliferation of hepatocytes and induction of HCC.